Scopus BioPharma Inc. Quarterly Depreciation in USD from Q1 2020 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Scopus BioPharma Inc. quarterly/annual Depreciation history and growth rate from Q1 2020 to Q2 2023.
  • Scopus BioPharma Inc. Depreciation for the quarter ending June 30, 2023 was $334.000, a 42.6% decline year-over-year.
  • Scopus BioPharma Inc. annual Depreciation for 2022 was $1.73K, a 15.2% increase from 2021.
  • Scopus BioPharma Inc. annual Depreciation for 2021 was $1.5K, a 4.17% increase from 2020.
  • Scopus BioPharma Inc. annual Depreciation for 2020 was $1.44K, a 117% increase from 2019.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $334 -$248 -42.6% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $231 -$378 -62.1% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-12
Q2 2022 $582 Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 $609 +$237 +63.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q1 2021 $372 +$16.00 +4.49% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-19
Q1 2020 $356 Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.